Treatment with Huperzine A Improves Cognition in Vascular Dementia Patients

Cell Biochemistry and Biophysics

Volumn 62, Issue 1, 2012, Pages 55-58

  Xu, Zhi Qiang ^a   Liang, Xiao Min ^a   Juan Wu, ^a   Zhang, Yuan Feng ^a   Zhu, Chun Xia ^a   Jiang, Xiao Jiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Activities of daily living; Clinical dementia rating; Cognition; Huperzine A; Mini mental state examination; Vascular dementia

Indexed keywords

ALKALOID; ASCORBIC ACID; HUPERZINE A; NEUROPROTECTIVE AGENT; SESQUITERPENE;

AGED; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTIINFARCT DEMENTIA; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL;

ACTIVITIES OF DAILY LIVING; AGED; ALKALOIDS; ASCORBIC ACID; COGNITION; DEMENTIA, VASCULAR; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PLACEBO EFFECT; SESQUITERPENES; SEVERITY OF ILLNESS INDEX;

EID: 84855575027     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9258-5     Document Type: Article

References (14)

1. Roman, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., et al. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250-260.
2. Dhoat, S., Ali, K., Bulpitt, C. J., & Rajkumar, C. (2008). Vascular compliance is reduced in vascular dementia and not in Alzheimer's disease. Age and Ageing, 37, 653-659.
3. Zhou, H., Deng, J., Li, J., Wang, Y., Zhang, M., & He, H. (2003). Study of the relationship between cigarette smoking, alcohol drinking and cognitive impairment among elderly people in China. Age and Ageing, 32, 205-210.
4. Roman, G. C. (2005). Cholinergic dysfunction in vascular dementia. Current Psychiatry Reports, 7, 18-26.
5. Wang, J., Zhang, H. Y., & Tang, X. C. (2009). Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta Pharmacologica Sinica, 30, 879-888.
6. Black, S., Roman, G. C., Geldmacher, D. S., Salloway, S., Hecker, J., Burns, A., et al. (2003). Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke, 34, 2323-2330.
7. Liu, J. S., Zhu, Y. L., Yu, C. M., Zhou, Y. Z., Han, Y. Y., Wu, F. W., et al. (1986). The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Can J Chem, 64, 837-839.
8. Li, Y. X., Zhang, R. Q., Li, C. R., & Jiang, X. H. (2007). Pharmacokinetics of huperzine A following oral administration to human volunteers. European Journal of Drug Metabolism and Pharmacokinetics, 32, 183-187.
9. Wang, B. S., Wang, H., Wei, Z. H., Song, Y. Y., Zhang, L., & Chen, H. Z. (2009). Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: An updated meta-analysis. Journal of Neural Transmission, 116, 457-465.
10. Zhang, H. Y., Zheng, C. Y., Yan, H., Wang, Z. F., Tang, L. L., Gao, X., et al. (2008). Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia. Chemico-Biological Interactions, 175, 396-402.
11. Wang, J., Zhang, H. Y., & Tang, X. C. (2010). Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. Journal of Neuroscience Research, 88, 807-815.
12. Park, P., Schachter, S., & Yaksh, T. (2010). Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats. Neuroscience Letters, 470, 6-9.
13. Xu, Z., Zheng, H., Law, S. L., Dong, S. D., Han, Y., & Xue, H. (2006). Effects of a memory enhancing peptide on cognitive abilities of brain-lesioned mice: Additivity with huperzine A and relative potency to tacrine. Journal of Peptide Science, 12, 72-78.
14. Wang, Q., & Chen, G. (2009). Pharmacokinetic behavior of huperzine A in plasma and cerebrospinal fluid after intranasal administration in rats. Biopharmaceutics and Drug Disposition, 30, 551-555.